Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection

NCT04756271 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

246

Enrollment

OTHER_GOV

Sponsor class

Conditions

Vaccine Adverse Reaction
Seroconversion

Interventions

BIOLOGICAL: SARS-Cov-2 neutralizing antibody titer

Sponsor

Zagazig University